| Literature DB >> 29615012 |
Tao Jin1, Weifeng Liu1, Hairong Xu1, Yuan Li1, Lin Hao1, Xiaohui Niu2.
Abstract
BACKGROUND: Whether reconstruction is more beneficial after iliosacral bone tumor resection remains controversial. Because of high rates of complications and recurrence, few patients benefit from reconstruction. The aim of this study is to assess functional outcomes and to reveal changes in the ipsilateral hip joint after partial iliosacral resection.Entities:
Keywords: Coverage; Function; Hip joint; Iliosacral bone tumor; No reconstruction
Mesh:
Year: 2018 PMID: 29615012 PMCID: PMC5883340 DOI: 10.1186/s12891-018-2023-9
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1I-A distance means the line from the iliosacral joint(I) to the upper line of the acetabulum(A) along the curved line. Line L and line B are the osteotomy lines. Defect length was defined as the distance between the osteotomy lines along the curved line
Fig. 2Acetabulum-head index(AHI). Line A is a horizontal measurement from the innermost surface of the head to a vertical line projected from the outermost margin of the acetabulum; line B is a similar horizontal measurement from the innermost surface of the head to a vertical line projected from the outermost surface of the head. The index is defined as A/B × 100
Fig. 3Center- edge angle. From the center (C) of the femoral head a line (C-A) is drawn through the center of the head of the opposite side. Perpendicularly to this line and through the center (C) the line (C-B) is raised. The CE angle denotes the angle between the line C-B and a line from C to the acetabular edge(E)
21 patients with pelvic tumors underwent iliosacral resection
| Case | Group | Sex | Age | Diagnosis | Stage | Resection | outcome | Local relapse | Metastases | Follow-up (M) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 1A | M | 39 | Metastatic tumor | – | Marginal | CDF | No | No | 32 |
| 2 | 1A | F | 66 | Chondrosarcoma | IB | inter-lesional | CDF | No | No | 72 |
| 3 | 1A | F | 25 | Desmoid tumor | 3 | inter-lesional | CDF | Y | No | 59 |
| 4 | 1A | F | 23 | Giant cell tumors | 3 | inter-lesional | CDF | Y | No | 48 |
| 5 | 1A | F | 33 | Giant cell tumors | 3 | inter-lesional | CDF | No | No | 163 |
| 6 | 1A | F | 45 | Undifferentiated pleomorphic sarcoma | IIB | Wide | CDF | No | No | 119 |
| 7 | 1A | F | 34 | Chondromyxoid fibroma | 3 | Wide | CDF | No | No | 12 |
| 8 | 1A | F | 23 | Ewing sarcoma | IIB | Wide | CDF | No | No | 26 |
| 9 | 1B | F | 34 | Chondrosarcoma | IB | inter-lesional | CDF | Y | No | 104 |
| 10 | 1B | M | 31 | Chondrosarcoma | IB | Marginal | CDF | No | No | 14 |
| 11 | 1B | M | 51 | Fibrosarcoma | IIB | Marginal | CDF | No | No | 40 |
| 12 | 1B | M | 20 | Osteosarcoma | IIB | Wide | CDF | No | No | 107 |
| 13 | 1B | M | 37 | Osteosarcoma | IIB | Wide | CDF | No | No | 39 |
| 14 | 1B | F | 31 | Giant cell tumors | 3 | inter-lesional | CDF | No | No | 114 |
| 15 | 1B | F | 23 | Giant cell tumors | 3 | inter-lesional | CDF | No | No | 152 |
| 16 | 1B | F | 23 | Chondrosarco | IB | Wide | CDF | No | No | 48 |
| 17 | 1B | M | 61 | Metastatic tumor | – | Wide | CDF | No | No | 24 |
| 18 | 1B | F | 65 | Chondrosarco | IB | Marginal | CDF | No | No | 17 |
| 19 | 2 | M | 22 | Ewing sarcoma | IIB | Wide | CDF | No | No | 21 |
| 20 | 2 | M | 25 | Ewing sarcoma | IIB | Wide | CDF | No | No | 24 |
| 21 | 2 | M | 37 | Chondrosarco | IB | Marginal | CDF | No | No | 36 |
CDF continously disease free
Results of all the data measured in each group
| Groups1 | Group2 |
| Groups1A | Groups1B |
| |
|---|---|---|---|---|---|---|
| Number(n) | 18 | 3 | – | 8 | 10 | – |
| Age | 36.9(20–66) | 28(22–37) | 0.333 | 36.0(23–66) | 37.6(20–65) | 0.829 |
| Bleeding(ml) | 1988(200–10,000) | 3266(1400–7000) | 0.384 | 1400(200–3000) | 2460(800–10,000) | 0.316 |
| Surgical time(min) | 194(100–280) | 440(210–720) | 0.241 | 179(120–250) | 206(100–280) | 0.358 |
| Pre-CE(°) | 32(27–40) | 29(27–33) | 0.221 | 32(29–35) | 32(27–40) | 0.738 |
| Post-CE(°) | 24(10–35) | 25(22–27) | 0.849 | 29(21–35) | 20(10–32)a | 0.006 |
| Change of CE(°) | 7(−1–20)a | 4(1-11) | 0.430 | 3(− 1–9) | 11(4–20)a | 0.003 |
| Pre-AHI(%) | 82(79–86) | 82(81–82) | 0.406 | 84(80–86) | 81(79–85) | 0.190 |
| Post-AHI(%) | 73(50–88) | 77(72–82) | 0.485 | 80(72–88) | 67(50–76)a | 0.002 |
| Change of AHI(%) | 9(−2–30)a | 4(− 1-10) | 0.380 | 3(− 2–13) | 14(6–30)a | 0.006 |
| MSTS(%) | 93.3(80–100) | 93.3(93.3–93.3) | 0.950 | 94.3(90–96.7) | 93(80–100) | 0.602 |
| TESS | 97.8(90.4–100) | 98.5(98.5–98.5) | 0.770 | 98.9(97.8–100) | 97.3(90.4–100) | 0.347 |
| LLD(cm) | 1.7(0–5) | 1.0(0–2) | 0.373 | 0.7(0–2) | 2.6(1–5) | 0.001 |
aExcept the patient who had a dislocation of the hip joint 60 months after operation. Pre:Preoperative,Post:Postoperative,CE:Center-edge angle, AHI:Acetabulum-head index,LLD:Limb-length discrepancy
Fig. 4A 31 years old women diagnosed with GCT underwent iliosacral resection without reconstruction (a). She began to bear weight 2 months after surgery and had a good function after 3 months after surgery(MSTS 93 score was 90%) (b). But the poor situation of AHI and CE angle were progressing and a dislocation was found at the followup 60 months after surgery, though the function was good (MSTS 93 score was 93%) (c)
Fig. 5A 23-year-old woman with Giant cell tumor of the left iliosacral joint (a, b). Photographs obtained 135 months postoperatively. The preoperational CE angle and AHI was 33°and 83%, compare with 25° and 76% 135 months after surgery. The final MSTS functional score of the patient was 29/30, her gait was almost normal (c)